LJI Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.28M Sell
37,598
-1,490
-4% -$86.9K 0.36% 28
2025
Q4
$2.11M Buy
+39,088
New +$1.88M 0.32% 38

Other funds holding BMY

LJI Wealth Management's BMY Position: Q1 2026 in Review

LJI Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 3.8% in Q1 2026, selling an estimated $86.9K and leaving 37,598 shares worth $2.28M. The position accounts for 0.36% of the portfolio, ranked #28.

LJI Wealth Management first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • LJI Wealth Management held 37,598 shares of Bristol-Myers Squibb worth $2.28M as of Q1 2026.
  • LJI Wealth Management sold 1,490 Bristol-Myers Squibb shares in Q1 2026, an estimated $86.9K.
  • Bristol-Myers Squibb made up 0.36% of LJI Wealth Management's portfolio in Q1 2026, its #28 holding.
  • LJI Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LJI Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.